BridgeBio Pharma (BBIO) Long-Term Investments (2018 - 2026)
BridgeBio Pharma's Long-Term Investments came in at $55.1 million for Q2 2026, down 49.0% from $108 million a year earlier and down 10.5% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Long-Term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma's Long-Term Investments was $79.97 million, down 44.4% from FY2024.
- Going back by year, Long-Term Investments was $143.75 million in FY2024.
- The Q2 2026 figure represents the lowest quarterly Long-Term Investments since Q1 2020.
- Year-over-year, Long-Term Investments has declined for five consecutive quarters, with an average decline of 39.1% over the last five quarters.
- Business Quant data shows BBIO's Long-Term Investments at $61.53 million (Q1 2026), $79.97 million (Q4 2025) and $92.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | BridgeBio Pharma | 12.85 Bn | 9.97 Bn | 228.63 Mn | 55.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.10 Mn |
| Mar 31, 2026 | 61.53 Mn |
| Dec 31, 2025 | 79.97 Mn |
| Sep 30, 2025 | 92.17 Mn |
| Jun 30, 2025 | 108.00 Mn |
| Mar 31, 2025 | 128.19 Mn |
| Dec 31, 2024 | 143.75 Mn |
| Sep 30, 2024 | 160.44 Mn |
| Jun 30, 2024 | 117.01 Mn |
| Jun 30, 2021 | 60.69 Mn |
| Mar 31, 2021 | 82.20 Mn |
| Mar 31, 2020 | 23.21 Mn |
| Dec 31, 2019 | 31.14 Mn |
| Sep 30, 2019 | 75.89 Mn |
| Jun 30, 2019 | 7.50 Mn |
| Dec 31, 2018 | 17.05 Mn |
API Access
BridgeBio Pharma Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();